Clinical Trial Update: DBPR108 Tablets in Type 2 Diabetes Mellitus Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for DBPR108 tablets in patients with Type 2 Diabetes Mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DBPR108 tablets (DBPR108)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED